Eric M. Dube - Jan 23, 2024 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Elizabeth E. Reed, Attorney-in-Fact
Stock symbol
TVTX
Transactions as of
Jan 23, 2024
Transactions value $
-$70,542
Form type
4
Date filed
1/25/2024, 04:10 PM
Previous filing
Sep 5, 2023
Next filing
Feb 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TVTX Common Stock Sale -$70.5K -7.87K -3.25% $8.96 235K Jan 23, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was made pursuant to a written plan meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of restricted stock units.